On ECHEMI
Home > Drugs > Warfarin Sodium Tablets

Warfarin Sodium Tablets

Ingredients

The main ingredients of this product are: Warfarin sodium

Name Description Content CAS NO. Manufacturer
Warfarin sodiumIngredients

129-06-6 22

Indication

Suitable for patients who need long-term continuous anticoagulation: It can prevent the formation and development of blood clots and is used to treat thromboembolic diseases; it can treat venous thrombosis after surgery or trauma, and can be used as an auxiliary medication for myocardial infarction; it can be used as a preventive medication for patients who have had thromboembolic diseases and those who are at risk of postoperative thrombotic complications.

Usage and Dosage

Oral administration, the usual dose for adults: avoid shock treatment and take 3 to 4 mg orally on the 1st to 3rd day (half the dose is enough for the elderly, frail and diabetic patients). After 3 days, a maintenance dose of 2.5 to 5mg per day can be given (the dose can be adjusted according to the coagulation time to achieve an inr value of 2 to 3). Due to the slow onset of action of this product, a temporary hypercoagulable state may exist due to the inhibition of plasma anticoagulant protein cells in the first 3 days of treatment. If an immediate anticoagulant effect is required, heparin can be applied at the same time at the beginning, and heparin can be stopped after this product has fully exerted its anticoagulant effect.

Adverse Reactions

Overdose can easily cause various bleeding. Early manifestations include ecchymosis, purpura, gingival bleeding, epistaxis, prolonged wound bleeding, and excessive menstrual flow. Bleeding can occur in any part, especially the urinary and digestive tracts. Intestinal wall hematoma can cause subacute intestinal obstruction, and subdural intracranial hematoma and puncture site hematoma can also be seen. Occasional adverse reactions include nausea, vomiting, diarrhea, itchy rash, allergic reactions and skin necrosis. Large amounts of oral administration may even cause bilateral breast necrosis, microangiopathy or hemolytic anemia, and extensive skin gangrene; excessive doses at one time are especially dangerous.

Precautions

It is contraindicated in patients with liver and kidney damage, severe hypertension, coagulation disorder with bleeding tendency, active ulcer, trauma, threatened abortion, and recent surgery. It is contraindicated during pregnancy. It should be used with caution in the elderly or during menstruation.

Special Population Medication

Precautions for children: The dosage should be adjusted according to individual needs. Precautions for pregnancy and lactation: The dosage should be adjusted according to individual needs. Precautions for the elderly: Drugs that enhance the anticoagulant effect of this product include: aspirin, sodium salicylate, glucagon, quinidine, indomethacin, phenylbutazone, quinine, uric acid, tolbutamide, metronidazole, allopurinol, erythromycin, chloramphenicol, certain aminoglycoside antibiotics, cephalosporins, beniodarone, cimetidine, clofibrate, dextrothyroxine, acetaminophen, etc. Drugs that reduce the anticoagulant effect of this product: phenytoin sodium, barbiturates, oral contraceptives, estrogen, cholestyramine, rifampicin, vitamin K, chlorthalidone, spironolactone, pyralidone, corticosteroids, etc. Drugs that cannot be used in combination with this product: epinephrine hydrochloride, amikacin, vitamin B12, metaraminolamine, oxytocin, chlorpromazine hydrochloride, vancomycin hydrochloride, etc. When this product is used in combination with chloral hydrate, its efficacy and toxicity are enhanced.

Drug Interactions

Drugs that enhance the anticoagulant effect of this product include: aspirin, sodium salicylate, glucagon, quinidine, indomethacin, phenylbutazone, quinine, uric acid, tolbutamide, metronidazole, allopurinol, erythromycin, chloramphenicol, certain aminoglycoside antibiotics, cephalosporins, beniodarone, cimetidine, clofibrate, dextrothyroxine, acetaminophen, etc. Drugs that reduce the anticoagulant effect of this product include: phenytoin sodium, barbiturates, oral contraceptives, estrogen, cholestyramine, rifampicin, vitamin K, chlorthalidone, spironolactone, primidone, corticosteroids, etc. Drugs that cannot be used in combination with this product include: epinephrine hydrochloride, amikacin, vitamin B12, metaraminolamine, oxytocin, chlorpromazine hydrochloride, vancomycin hydrochloride, etc. When this product is used in combination with chloral hydrate, its efficacy and toxicity are enhanced, so it should be used with caution in a reduced dose. Impaired absorption or decreased synthesis of vitamin K also affects the anticoagulant effect of this product.

Storage

Keep away from light and store in sealed container.

Packaging Specification

2.5mg

Manufacturer

Beijing Jialin Pharmaceutical Co., Ltd.

  • Founded in:

    1977-08-05
  • Address:

    No. 2 Jiuxianqiao Road, Dashanzi, Dongzhimenwai, Chaoyang District, Beijing
  • Tax NO.:

    911101051016610948
  • Registered Funds:

    30.5 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.